Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Infectious Diseases›Sporotrichosis
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Sporotrichosis

Infectious Diseases · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 6 min read

The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (1,190 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with sporothrix.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Sporotrichoses; Sporothrix Infection; Infection, Sporothrix; Sporothrix Infections; Sporothrix schenckii Infection; Infection, Sporothrix schenckii; Sporothrix schenckii Infections; Sporothrix brasiliensis Infection.

Where it fits in the MeSH classification

Broader topics
Dermatomycoses

Related concepts

  • Sporothrix

Research landscape

PubMed indexes 2,193 records tagged with the MeSH heading “Sporotrichosis” (counts retrieved 2026-10-29). 425 of them (19.4%) were published from 2020 onward, and the busiest period so far is through 1999 with 1,052 records.

Reviews account for 229 records (10.4%) and meta-analyses for 5. Randomized controlled trials number 6 (0.3%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,052 records; 2000-2009: 279 records; 2010-2019: 437 records; 2020 onward: 425 records1,052through 19992792000-20094372010-20194252020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,052
2000-2009279
2010-2019437
2020 onward425
Share of records by publication typeReviews: 10.4 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 0.3 percentReviews10.4% (229)Meta-analyses0.2% (5)Randomized controlled trials0.3% (6)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,193 PubMed records
TypeRecordsShare
Reviews22910.4%
Meta-analyses50.2%
Randomized controlled trials60.3%

Method: PubMed query "Sporotrichosis"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in infectious diseases

Infectious disease evidence combines microbiology, epidemiology and clinical trials. Laboratory studies identify pathogens and how they cause harm; surveillance and outbreak investigations describe who is affected and how infection spreads; trials establish whether treatments and vaccines work. Results depend on place and time, because pathogens evolve and resistance patterns and population immunity change. Check when and where the data were collected, how cases were defined and how up to date the evidence is.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Molecular Diagnosis of Pathogenic Sporothrix Species
Rodrigues AM, de Hoog GS, de Camargo ZP
2015Research article
Design not recorded in structured metadata
139cc by
PMID 26623643 · DOI · PMC4666615
Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis
Teixeira MM, de Almeida LG, Kubitschek-Barreira P, Alves FL, Kioshima ES, Abadio AK, et al.
2014Research article
Design not recorded in structured metadata
118cc by
PMID 25351875 · DOI · PMC4226871
Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo, Brazil
Montenegro H, Rodrigues AM, Dias MA, da Silva EA, Bernardi F, de Camargo ZP
2014Research article
Design not recorded in structured metadata
111cc by
PMID 25407096 · DOI · PMC4244058
Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global Cohort
Schapiro S, Pulciano N, Galindo-Ramirez J, Rau N, Tuells J, Agudelo Higuita NI, et al.
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41732997 · DOI · PMC12930329

Molecular Diagnosis of Pathogenic Sporothrix Species [1]

Research article Rodrigues AM, de Hoog GS, de Camargo ZP · · 2015 · cited 139 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundSporotrichosis is a chronic (sub)cutaneous infection caused by thermodimorphic fungi in the order, Ophiostomatales.
Closing excerpt
The method proved to be simple, high throughput, sensitive, and accurate for diagnosing sporotrichosis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (293 words)

BackgroundSporotrichosis is a chronic (sub)cutaneous infection caused by thermodimorphic fungi in the order, Ophiostomatales. These fungi are characterized by major differences in routes of transmission, host predilections, species virulence, and susceptibilities to antifungals. Sporothrix species emerge in the form of outbreaks. Large zoonoses and sapronoses are ongoing in Brazil and China, respectively. Current diagnostic methods based on morphology and physiology are inaccurate due to closely related phenotypes with overlapping components between pathogenic and non-pathogenic Sporothrix. There is a critical need for new diagnostic tools that are specific, sensitive, and cost-effective.MethodologyWe developed a panel of novel markers, based on calmodulin (CAL) gene sequences, for the large-scale diagnosis and epidemiology of clinically relevant members of the Sporothrix genus, and its relative, Ophiostoma. We identified specific PCR-based markers for S. brasiliensis, S. schenckii, S. globosa, S. mexicana, S. pallida, and O. stenoceras. We employed a murine model of disseminated sporotrichosis to optimize a PCR assay for detecting Sporothrix in clinical specimens.ResultsPrimer-BLAST searches revealed candidate sequences that were conserved within a single species. Species-specific primers showed no significant homology with human, mouse, or microorganisms outside the Sporothrix genus. The detection limit was 10-100 fg of DNA in a single round of PCR for identifying S. brasiliensis, S. schenckii, S. globosa, S. mexicana, and S. pallida. A simple, direct PCR assay, with conidia as a source of DNA, was effective for rapid, low-cost genotyping. Samples from a murine model of disseminated sporotrichosis confirmed the feasibility of detecting S. brasiliensis and S. schenckii DNA in spleen, liver, lungs, heart, brain, kidney, tail, and feces of infected animals.ConclusionsThis PCR-based method could successfully detect and identify a single species in samples from cultures and from clinical specimens. The method proved to be simple, high throughput, sensitive, and accurate for diagnosing sporotrichosis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26623643 · DOI · PMC4666615

Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis [2]

Research article Teixeira MM, de Almeida LG, Kubitschek-Barreira P, Alves FL, Kioshima ES, Abadio AK, et al. · · 2014 · cited 118 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundThe fungal genus Sporothrix includes at least four human pathogenic species.
Closing excerpt
Moreover, the striking differences found in comparison with other dimorphic fungi revealed that dimorphism in these close relatives of plant-associated Sordariomycetes is a case of convergent evolution, stressing the importance of this morphogenetic change in fungal pathogenesis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (343 words)

BackgroundThe fungal genus Sporothrix includes at least four human pathogenic species. One of these species, S. brasiliensis, is the causal agent of a major ongoing zoonotic outbreak of sporotrichosis in Brazil. Elsewhere, sapronoses are caused by S. schenckii and S. globosa. The major aims on this comparative genomic study are: 1) to explore the presence of virulence factors in S. schenckii and S. brasiliensis; 2) to compare S. brasiliensis, which is cat-transmitted and infects both humans and cats with S. schenckii, mainly a human pathogen; 3) to compare these two species to other human pathogens (Onygenales) with similar thermo-dimorphic behavior and to other plant-associated Sordariomycetes.ResultsThe genomes of S. schenckii and S. brasiliensis were pyrosequenced to 17x and 20x coverage comprising a total of 32.3 Mb and 33.2 Mb, respectively. Pair-wise genome alignments revealed that the two species are highly syntenic showing 97.5% average sequence identity. Phylogenomic analysis reveals that both species diverged about 3.8-4.9 MYA suggesting a recent event of speciation. Transposable elements comprise respectively 0.34% and 0.62% of the S. schenckii and S. brasiliensis genomes and expansions of Gypsy-like elements was observed reflecting the accumulation of repetitive elements in the S. brasiliensis genome. Mitochondrial genomic comparisons showed the presence of group-I intron encoding homing endonucleases (HE's) exclusively in S. brasiliensis. Analysis of protein family expansions and contractions in the Sporothrix lineage revealed expansion of LysM domain-containing proteins, small GTPases, PKS type1 and leucin-rich proteins. In contrast, a lack of polysaccharide lyase genes that are associated with decay of plants was observed when compared to other Sordariomycetes and dimorphic fungal pathogens, suggesting evolutionary adaptations from a plant pathogenic or saprobic to an animal pathogenic life style.ConclusionsComparative genomic data suggest a unique ecological shift in the Sporothrix lineage from plant-association to mammalian parasitism, which contributes to the understanding of how environmental interactions may shape fungal virulence. . Moreover, the striking differences found in comparison with other dimorphic fungi revealed that dimorphism in these close relatives of plant-associated Sordariomycetes is a case of convergent evolution, stressing the importance of this morphogenetic change in fungal pathogenesis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 25351875 · DOI · PMC4226871

Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo, Brazil [3]

Research article Montenegro H, Rodrigues AM, Dias MA, da Silva EA, Bernardi F, de Camargo ZP · · 2014 · cited 111 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundSporotrichosis is a mycotic infectious disease that is generally acquired by traumatic inoculation of contaminated materials especially from plant debris or through bites and scratches from diseased animals, such as domestic cats.
Closing excerpt
The feline sporotrichosis epidemic shows no signs of slowing, and this epidemiological pattern may require specific public health strategies to control future outbreaks.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (301 words)

BackgroundSporotrichosis is a mycotic infectious disease that is generally acquired by traumatic inoculation of contaminated materials especially from plant debris or through bites and scratches from diseased animals, such as domestic cats. It affects the skin, lymphatic system, and other organs in the warm-blooded host. Etiological agents are embedded in the plant-associated order Ophiostomatales. With essential differences between possible outbreak sources and ecological niche, host-environment interactions are classic determinants of risk factors for disease acquisition. Sporotrichosis outbreaks with zoonotic transmission, such as those that are ongoing in southern and southeastern Brazil, have highlighted the threat of cross-species pathogen transmission. Sporothrix brasiliensis has emerged as a human threat owing to the intimate contact pattern between diseased cats and humans in endemic areas.ResultsWe describe the recent emergence of feline sporotrichosis in the metropolitan region of São Paulo, Brazil, with an overwhelming occurrence of S. brasiliensis as the etiological agent. A phylogenetic and a haplotype approach were used to investigate the origin of this epidemic and the impact of feline transmission on genetic diversity. During the last 3-year period, 163 cases of feline sporotrichosis were reported in São Paulo with proven S. brasiliensis culture. The haplotype diversity of feline S. brasiliensis isolates revealed the expansion of a clonal population with low genetic diversity. Haplotype analysis confirmed that isolates from São Paulo shared the haplotype originated in the long-lasting outbreak of cat-transmitted sporotrichosis in Rio de Janeiro, which differed from the haplotype circulating in the Rio Grande do Sul epidemic.ConclusionsThe fast spread of sporotrichosis in a short period of time highlights the potential for outbreaks and suggests that the mycosis may affect an urban population with a high concentration of susceptible felines. The feline sporotrichosis epidemic shows no signs of slowing, and this epidemiological pattern may require specific public health strategies to control future outbreaks.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 25407096 · DOI · PMC4244058

Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global Cohort [4]

Research article Schapiro S, Pulciano N, Galindo-Ramirez J, Rau N, Tuells J, Agudelo Higuita NI, et al. · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundSporotrichosis is a dimorphic fungal infection of increasing global relevance.
Closing excerpt
Earlier recognition, optimised antifungal therapy, and use of inflammatory markers to guide risk stratification may improve outcomes and inform prevention strategies.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (253 words)

BackgroundSporotrichosis is a dimorphic fungal infection of increasing global relevance. Although usually cutaneous or lymphocutaneous, disseminated disease occurs in immunocompromised hosts. Large-scale data on its epidemiology, treatment and outcomes remain limited.ObjectivesTo characterise the clinical features, comorbidities, antifungal prescribing patterns and one-year mortality associated with sporotrichosis, with emphasis on patients with HIV and other forms of immunosuppression.Patients/methodsWe performed a retrospective global cohort study using the TriNetX Research Network. Adults (≥ 18 years) diagnosed with sporotrichosis were identified using ICD-9/10 codes (1995-2024). Demographics, comorbidities, laboratory parameters and antifungal prescriptions were analysed. The primary outcome was all-cause mortality at 1 year. Secondary outcomes included hospitalisation and admission to the intensive care unit (ICU).ResultsAmong 2124 adults, the mean age was 52 years, and 56.5% were female. Nearly half of the cases originated internationally, with the southeastern United States accounting for the majority of domestic cases. Neoplasms (25%) and diabetes (11%) were the most common comorbidities. Lymphocutaneous disease was uncommon (9%), and disseminated infection occurred in 1% of cases. One-year mortality was 17%, with a higher risk among older adults and those with neoplasms, lymphocutaneous or disseminated infection or hyperferritinemia. Seventeen patients (0.8%) had HIV and were more likely to have pulmonary or disseminated disease. Itraconazole was the most commonly prescribed antifungal (52%), while the use of amphotericin B remained low (ConclusionsSporotrichosis causes substantial global mortality. Outcomes appear driven by host factors and gaps in guideline-based management. Earlier recognition, optimised antifungal therapy, and use of inflammatory markers to guide risk stratification may improve outcomes and inform prevention strategies.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41732997 · DOI · PMC12930329

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Sporothrix schenckii and Sporotrichosis [5]
    Barros MB, de Almeida Paes R, Schubach AO · Clin Microbiol Rev · 2011 · cited 426 times (Europe PMC)
  • Research article Global epidemiology of sporotrichosis [6]
    Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S · Med Mycol · 2015 · cited 337 times (Europe PMC)
  • Research article Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America [7]
    Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America · Clin Infect Dis · 2007 · cited 298 times (Europe PMC)
  • Research article Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission [8]
    Gremião ID, Miranda LH, Reis EG, Rodrigues AM, Pereira SA · PLoS Pathog · 2017 · cited 230 times (Europe PMC)
  • Research article The threat of emerging and re-emerging pathogenic Sporothrix species [9]
    Rodrigues AM, Della Terra PP, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP · Mycopathologia · 2020 · cited 153 times (Europe PMC)
  • Research article Sporothrix schenckii complex and sporotrichosis, an emerging health problem [10]
    López-Romero E, Reyes-Montes Mdel R, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, et al. · Future Microbiol · 2011 · cited 134 times (Europe PMC)

References

  1. Rodrigues AM, de Hoog GS, de Camargo ZP. Molecular Diagnosis of Pathogenic Sporothrix Species. . 2015. PMID 26623643 · DOI · PMC4666615
  2. Teixeira MM, de Almeida LG, Kubitschek-Barreira P, Alves FL, Kioshima ES, Abadio AK, et al.. Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis. . 2014. PMID 25351875 · DOI · PMC4226871
  3. Montenegro H, Rodrigues AM, Dias MA, da Silva EA, Bernardi F, de Camargo ZP. Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo, Brazil. . 2014. PMID 25407096 · DOI · PMC4244058
  4. Schapiro S, Pulciano N, Galindo-Ramirez J, Rau N, Tuells J, Agudelo Higuita NI, et al.. Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global Cohort. . 2026. PMID 41732997 · DOI · PMC12930329
  5. Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev. 2011. PMID 21976602 · DOI · PMC3194828
  6. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015. PMID 25526781 · DOI
  7. Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007. PMID 17968818 · DOI
  8. Gremião ID, Miranda LH, Reis EG, Rodrigues AM, Pereira SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017. PMID 28103311 · DOI · PMC5245785
  9. Rodrigues AM, Della Terra PP, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia. 2020. PMID 32052359 · DOI
  10. López-Romero E, Reyes-Montes Mdel R, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, et al.. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011. PMID 21162638 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • TineaInfectious Diseases
  • ChromoblastomycosisInfectious Diseases
  • MycetomaInfectious Diseases
  • Tinea CapitisInfectious Diseases
  • Tinea PedisInfectious Diseases
  • BlastomycosisInfectious Diseases

All 102 articles in Infectious Diseases →

At a glance

2,193
PubMed records on this heading
19%
published since 2020
229
review articles
6
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • TineaInfectious Diseases
  • ChromoblastomycosisInfectious Diseases
  • MycetomaInfectious Diseases
  • Tinea CapitisInfectious Diseases
  • Tinea PedisInfectious Diseases

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support